Blog

Eyenuk’s AI Eye Screening System for Diabetic Retinopathy Demonstrates Exceptional Performance in a Prospective, Multi-Center, Pivotal Clinical Trial

LOS ANGELES, Calif., April 28, 2019 – Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today results from its landmark prospective, multi-center, pivotal clinical trial to validate the EyeArt® AI Eye Screening System for autonomous detection of diabetic retinopathy (DR),

Researchers Study Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic Retinopathy

LOS ANGELES, June 5, 2019 – Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today that data from scientific studies related to the screening efficacy of the EyeArt® AI Eye Screening System and the impact of using the EyeArt AI

German Diabetes Clinic Increases Diabetic Retinopathy Screenings Provided from Zero to Thousands After Implementing Eyenuk’s EyeArt AI Eye Screening System

LOS ANGELES, CA, May 16, 2019 – Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today results of its expansion into Germany. Since adopting the EyeArt AI Eye Screening System in October 2018, Diabetes Center Mergentheim has screened thousands of

Eyenuk, Inc. transitioning to a new logo

Eyenuk’s logo was originally conceived back in early 2013 , to give the viewer the impression of staring at a “real” 3-dimensional eye, while giving it an orange hue to be consistent with the Eyenuk branding. The logo’s font was chosen to serve as a logo on its own when required. Our old logo has

Eyenuk successfully clears HIPAA audit by A-Lign

Eyenuk Inc., a global artificial intelligence (AI) medical technology company, is pleased to announce that it has successfully cleared an independent HIPAA audit. As a leader in real-world AI eye screening for autonomous disease detection, the team at Eyenuk Inc. understands and embraces the responsibility to keep patient data both private and secure, and they